INS and type 2 diabetes mellitus: Indeed, the importance of PPARγ in regulating the insulin sensitivity has motivated research groups in both academia and the pharmaceutical industry to devote increasing efforts toward developing synthetic PPARγ agonists, which could be of therapeutic use in patients affected by T2DM [8].